Medical Care
Global Drug Delivery Nanoparticles Formulation Market Research Report 2025
- Oct 04, 25
- ID: 524102
- Pages: 84
- Figures: 89
- Views: 18
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Nanoparticles Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Nanoparticles Formulation.
The Drug Delivery Nanoparticles Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Delivery Nanoparticles Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Nanoparticles Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Bioarticles
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
Segment by Type
Oral Preparation
Injectable Preparations
Skin Preparations
Others
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Nanoparticles Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Drug Delivery Nanoparticles Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Delivery Nanoparticles Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Nanoparticles Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Bioarticles
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
Segment by Type
Oral Preparation
Injectable Preparations
Skin Preparations
Others
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Nanoparticles Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Preparation
1.2.3 Injectable Preparations
1.2.4 Skin Preparations
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Delivery Nanoparticles Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Nanoparticles Formulation Market Perspective (2020-2031)
2.2 Global Drug Delivery Nanoparticles Formulation Growth Trends by Region
2.2.1 Global Drug Delivery Nanoparticles Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Delivery Nanoparticles Formulation Historic Market Size by Region (2020-2025)
2.2.3 Drug Delivery Nanoparticles Formulation Forecasted Market Size by Region (2026-2031)
2.3 Drug Delivery Nanoparticles Formulation Market Dynamics
2.3.1 Drug Delivery Nanoparticles Formulation Industry Trends
2.3.2 Drug Delivery Nanoparticles Formulation Market Drivers
2.3.3 Drug Delivery Nanoparticles Formulation Market Challenges
2.3.4 Drug Delivery Nanoparticles Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue
3.1.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue (2020-2025)
3.1.2 Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Drug Delivery Nanoparticles Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Delivery Nanoparticles Formulation Revenue
3.4 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio
3.4.1 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Nanoparticles Formulation Revenue in 2024
3.5 Global Key Players of Drug Delivery Nanoparticles Formulation Head office and Area Served
3.6 Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
3.7 Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Nanoparticles Formulation Breakdown Data by Type
4.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Type (2020-2025)
4.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2026-2031)
5 Drug Delivery Nanoparticles Formulation Breakdown Data by Application
5.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Application (2020-2025)
5.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
6.2 North America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
6.4 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
7.2 Europe Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
7.4 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
8.2 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
9.2 Latin America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
9.4 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
10.2 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Bioarticles
11.1.1 CD Bioarticles Company Details
11.1.2 CD Bioarticles Business Overview
11.1.3 CD Bioarticles Drug Delivery Nanoparticles Formulation Introduction
11.1.4 CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.1.5 CD Bioarticles Recent Development
11.2 Evonik Health Care
11.2.1 Evonik Health Care Company Details
11.2.2 Evonik Health Care Business Overview
11.2.3 Evonik Health Care Drug Delivery Nanoparticles Formulation Introduction
11.2.4 Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.2.5 Evonik Health Care Recent Development
11.3 Sanner
11.3.1 Sanner Company Details
11.3.2 Sanner Business Overview
11.3.3 Sanner Drug Delivery Nanoparticles Formulation Introduction
11.3.4 Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.3.5 Sanner Recent Development
11.4 Lubrizol Life Science Health (LLS Health)
11.4.1 Lubrizol Life Science Health (LLS Health) Company Details
11.4.2 Lubrizol Life Science Health (LLS Health) Business Overview
11.4.3 Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Introduction
11.4.4 Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.4.5 Lubrizol Life Science Health (LLS Health) Recent Development
11.5 Kindeva Drug Delivery
11.5.1 Kindeva Drug Delivery Company Details
11.5.2 Kindeva Drug Delivery Business Overview
11.5.3 Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Introduction
11.5.4 Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.5.5 Kindeva Drug Delivery Recent Development
11.6 Beijing TheraXyte Biotechnology
11.6.1 Beijing TheraXyte Biotechnology Company Details
11.6.2 Beijing TheraXyte Biotechnology Business Overview
11.6.3 Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Introduction
11.6.4 Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.6.5 Beijing TheraXyte Biotechnology Recent Development
11.7 Altasciences
11.7.1 Altasciences Company Details
11.7.2 Altasciences Business Overview
11.7.3 Altasciences Drug Delivery Nanoparticles Formulation Introduction
11.7.4 Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.7.5 Altasciences Recent Development
11.8 Stevanato Group
11.8.1 Stevanato Group Company Details
11.8.2 Stevanato Group Business Overview
11.8.3 Stevanato Group Drug Delivery Nanoparticles Formulation Introduction
11.8.4 Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.8.5 Stevanato Group Recent Development
11.9 RiboBio
11.9.1 RiboBio Company Details
11.9.2 RiboBio Business Overview
11.9.3 RiboBio Drug Delivery Nanoparticles Formulation Introduction
11.9.4 RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.9.5 RiboBio Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Drug Delivery Nanoparticles Formulation Introduction
11.10.4 Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.10.5 Lonza Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Introduction
11.11.4 Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Catalent
11.12.1 Catalent Company Details
11.12.2 Catalent Business Overview
11.12.3 Catalent Drug Delivery Nanoparticles Formulation Introduction
11.12.4 Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.12.5 Catalent Recent Development
11.13 Asymchem
11.13.1 Asymchem Company Details
11.13.2 Asymchem Business Overview
11.13.3 Asymchem Drug Delivery Nanoparticles Formulation Introduction
11.13.4 Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.13.5 Asymchem Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Details
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Drug Delivery Nanoparticles Formulation Introduction
11.14.4 Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.14.5 Samsung Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Preparation
1.2.3 Injectable Preparations
1.2.4 Skin Preparations
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Delivery Nanoparticles Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Nanoparticles Formulation Market Perspective (2020-2031)
2.2 Global Drug Delivery Nanoparticles Formulation Growth Trends by Region
2.2.1 Global Drug Delivery Nanoparticles Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Delivery Nanoparticles Formulation Historic Market Size by Region (2020-2025)
2.2.3 Drug Delivery Nanoparticles Formulation Forecasted Market Size by Region (2026-2031)
2.3 Drug Delivery Nanoparticles Formulation Market Dynamics
2.3.1 Drug Delivery Nanoparticles Formulation Industry Trends
2.3.2 Drug Delivery Nanoparticles Formulation Market Drivers
2.3.3 Drug Delivery Nanoparticles Formulation Market Challenges
2.3.4 Drug Delivery Nanoparticles Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue
3.1.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue (2020-2025)
3.1.2 Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Drug Delivery Nanoparticles Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Delivery Nanoparticles Formulation Revenue
3.4 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio
3.4.1 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Nanoparticles Formulation Revenue in 2024
3.5 Global Key Players of Drug Delivery Nanoparticles Formulation Head office and Area Served
3.6 Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
3.7 Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Nanoparticles Formulation Breakdown Data by Type
4.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Type (2020-2025)
4.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2026-2031)
5 Drug Delivery Nanoparticles Formulation Breakdown Data by Application
5.1 Global Drug Delivery Nanoparticles Formulation Historic Market Size by Application (2020-2025)
5.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
6.2 North America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
6.4 North America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
7.2 Europe Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
7.4 Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
8.2 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
9.2 Latin America Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
9.4 Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size (2020-2031)
10.2 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Bioarticles
11.1.1 CD Bioarticles Company Details
11.1.2 CD Bioarticles Business Overview
11.1.3 CD Bioarticles Drug Delivery Nanoparticles Formulation Introduction
11.1.4 CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.1.5 CD Bioarticles Recent Development
11.2 Evonik Health Care
11.2.1 Evonik Health Care Company Details
11.2.2 Evonik Health Care Business Overview
11.2.3 Evonik Health Care Drug Delivery Nanoparticles Formulation Introduction
11.2.4 Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.2.5 Evonik Health Care Recent Development
11.3 Sanner
11.3.1 Sanner Company Details
11.3.2 Sanner Business Overview
11.3.3 Sanner Drug Delivery Nanoparticles Formulation Introduction
11.3.4 Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.3.5 Sanner Recent Development
11.4 Lubrizol Life Science Health (LLS Health)
11.4.1 Lubrizol Life Science Health (LLS Health) Company Details
11.4.2 Lubrizol Life Science Health (LLS Health) Business Overview
11.4.3 Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Introduction
11.4.4 Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.4.5 Lubrizol Life Science Health (LLS Health) Recent Development
11.5 Kindeva Drug Delivery
11.5.1 Kindeva Drug Delivery Company Details
11.5.2 Kindeva Drug Delivery Business Overview
11.5.3 Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Introduction
11.5.4 Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.5.5 Kindeva Drug Delivery Recent Development
11.6 Beijing TheraXyte Biotechnology
11.6.1 Beijing TheraXyte Biotechnology Company Details
11.6.2 Beijing TheraXyte Biotechnology Business Overview
11.6.3 Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Introduction
11.6.4 Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.6.5 Beijing TheraXyte Biotechnology Recent Development
11.7 Altasciences
11.7.1 Altasciences Company Details
11.7.2 Altasciences Business Overview
11.7.3 Altasciences Drug Delivery Nanoparticles Formulation Introduction
11.7.4 Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.7.5 Altasciences Recent Development
11.8 Stevanato Group
11.8.1 Stevanato Group Company Details
11.8.2 Stevanato Group Business Overview
11.8.3 Stevanato Group Drug Delivery Nanoparticles Formulation Introduction
11.8.4 Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.8.5 Stevanato Group Recent Development
11.9 RiboBio
11.9.1 RiboBio Company Details
11.9.2 RiboBio Business Overview
11.9.3 RiboBio Drug Delivery Nanoparticles Formulation Introduction
11.9.4 RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.9.5 RiboBio Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Drug Delivery Nanoparticles Formulation Introduction
11.10.4 Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.10.5 Lonza Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Introduction
11.11.4 Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Catalent
11.12.1 Catalent Company Details
11.12.2 Catalent Business Overview
11.12.3 Catalent Drug Delivery Nanoparticles Formulation Introduction
11.12.4 Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.12.5 Catalent Recent Development
11.13 Asymchem
11.13.1 Asymchem Company Details
11.13.2 Asymchem Business Overview
11.13.3 Asymchem Drug Delivery Nanoparticles Formulation Introduction
11.13.4 Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.13.5 Asymchem Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Details
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Drug Delivery Nanoparticles Formulation Introduction
11.14.4 Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025)
11.14.5 Samsung Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Preparation
Table 3. Key Players of Injectable Preparations
Table 4. Key Players of Skin Preparations
Table 5. Key Players of Others
Table 6. Global Drug Delivery Nanoparticles Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drug Delivery Nanoparticles Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Drug Delivery Nanoparticles Formulation Market Share by Region (2020-2025)
Table 10. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Drug Delivery Nanoparticles Formulation Market Share by Region (2026-2031)
Table 12. Drug Delivery Nanoparticles Formulation Market Trends
Table 13. Drug Delivery Nanoparticles Formulation Market Drivers
Table 14. Drug Delivery Nanoparticles Formulation Market Challenges
Table 15. Drug Delivery Nanoparticles Formulation Market Restraints
Table 16. Global Drug Delivery Nanoparticles Formulation Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Drug Delivery Nanoparticles Formulation Market Share by Players (2020-2025)
Table 18. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2024)
Table 19. Ranking of Global Top Drug Delivery Nanoparticles Formulation Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Drug Delivery Nanoparticles Formulation Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Drug Delivery Nanoparticles Formulation, Headquarters and Area Served
Table 22. Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
Table 23. Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Delivery Nanoparticles Formulation Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Type (2020-2025)
Table 27. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Type (2026-2031)
Table 29. Global Drug Delivery Nanoparticles Formulation Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Application (2020-2025)
Table 31. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Application (2026-2031)
Table 33. North America Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 48. CD Bioarticles Company Details
Table 49. CD Bioarticles Business Overview
Table 50. CD Bioarticles Drug Delivery Nanoparticles Formulation Product
Table 51. CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 52. CD Bioarticles Recent Development
Table 53. Evonik Health Care Company Details
Table 54. Evonik Health Care Business Overview
Table 55. Evonik Health Care Drug Delivery Nanoparticles Formulation Product
Table 56. Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 57. Evonik Health Care Recent Development
Table 58. Sanner Company Details
Table 59. Sanner Business Overview
Table 60. Sanner Drug Delivery Nanoparticles Formulation Product
Table 61. Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 62. Sanner Recent Development
Table 63. Lubrizol Life Science Health (LLS Health) Company Details
Table 64. Lubrizol Life Science Health (LLS Health) Business Overview
Table 65. Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Product
Table 66. Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 67. Lubrizol Life Science Health (LLS Health) Recent Development
Table 68. Kindeva Drug Delivery Company Details
Table 69. Kindeva Drug Delivery Business Overview
Table 70. Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Product
Table 71. Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 72. Kindeva Drug Delivery Recent Development
Table 73. Beijing TheraXyte Biotechnology Company Details
Table 74. Beijing TheraXyte Biotechnology Business Overview
Table 75. Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Product
Table 76. Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 77. Beijing TheraXyte Biotechnology Recent Development
Table 78. Altasciences Company Details
Table 79. Altasciences Business Overview
Table 80. Altasciences Drug Delivery Nanoparticles Formulation Product
Table 81. Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 82. Altasciences Recent Development
Table 83. Stevanato Group Company Details
Table 84. Stevanato Group Business Overview
Table 85. Stevanato Group Drug Delivery Nanoparticles Formulation Product
Table 86. Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 87. Stevanato Group Recent Development
Table 88. RiboBio Company Details
Table 89. RiboBio Business Overview
Table 90. RiboBio Drug Delivery Nanoparticles Formulation Product
Table 91. RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 92. RiboBio Recent Development
Table 93. Lonza Company Details
Table 94. Lonza Business Overview
Table 95. Lonza Drug Delivery Nanoparticles Formulation Product
Table 96. Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 97. Lonza Recent Development
Table 98. Thermo Fisher Scientific Company Details
Table 99. Thermo Fisher Scientific Business Overview
Table 100. Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Product
Table 101. Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 102. Thermo Fisher Scientific Recent Development
Table 103. Catalent Company Details
Table 104. Catalent Business Overview
Table 105. Catalent Drug Delivery Nanoparticles Formulation Product
Table 106. Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 107. Catalent Recent Development
Table 108. Asymchem Company Details
Table 109. Asymchem Business Overview
Table 110. Asymchem Drug Delivery Nanoparticles Formulation Product
Table 111. Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 112. Asymchem Recent Development
Table 113. Samsung Biologics Company Details
Table 114. Samsung Biologics Business Overview
Table 115. Samsung Biologics Drug Delivery Nanoparticles Formulation Product
Table 116. Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 117. Samsung Biologics Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Drug Delivery Nanoparticles Formulation Picture
Figure 2. Global Drug Delivery Nanoparticles Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Delivery Nanoparticles Formulation Market Share by Type: 2024 VS 2031
Figure 4. Oral Preparation Features
Figure 5. Injectable Preparations Features
Figure 6. Skin Preparations Features
Figure 7. Others Features
Figure 8. Global Drug Delivery Nanoparticles Formulation Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Drug Delivery Nanoparticles Formulation Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Delivery Nanoparticles Formulation Report Years Considered
Figure 14. Global Drug Delivery Nanoparticles Formulation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Drug Delivery Nanoparticles Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug Delivery Nanoparticles Formulation Market Share by Region: 2024 VS 2031
Figure 17. Global Drug Delivery Nanoparticles Formulation Market Share by Players in 2024
Figure 18. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery Nanoparticles Formulation Revenue in 2024
Figure 20. North America Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 22. United States Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 26. Germany Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Region (2020-2031)
Figure 34. China Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 42. Mexico Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 46. Turkey Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. CD Bioarticles Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 50. Evonik Health Care Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 51. Sanner Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 52. Lubrizol Life Science Health (LLS Health) Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 53. Kindeva Drug Delivery Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 54. Beijing TheraXyte Biotechnology Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 55. Altasciences Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 56. Stevanato Group Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 57. RiboBio Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 58. Lonza Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 60. Catalent Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 61. Asymchem Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 62. Samsung Biologics Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Preparation
Table 3. Key Players of Injectable Preparations
Table 4. Key Players of Skin Preparations
Table 5. Key Players of Others
Table 6. Global Drug Delivery Nanoparticles Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drug Delivery Nanoparticles Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Drug Delivery Nanoparticles Formulation Market Share by Region (2020-2025)
Table 10. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Drug Delivery Nanoparticles Formulation Market Share by Region (2026-2031)
Table 12. Drug Delivery Nanoparticles Formulation Market Trends
Table 13. Drug Delivery Nanoparticles Formulation Market Drivers
Table 14. Drug Delivery Nanoparticles Formulation Market Challenges
Table 15. Drug Delivery Nanoparticles Formulation Market Restraints
Table 16. Global Drug Delivery Nanoparticles Formulation Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Drug Delivery Nanoparticles Formulation Market Share by Players (2020-2025)
Table 18. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2024)
Table 19. Ranking of Global Top Drug Delivery Nanoparticles Formulation Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Drug Delivery Nanoparticles Formulation Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Drug Delivery Nanoparticles Formulation, Headquarters and Area Served
Table 22. Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
Table 23. Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Delivery Nanoparticles Formulation Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Type (2020-2025)
Table 27. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Type (2026-2031)
Table 29. Global Drug Delivery Nanoparticles Formulation Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Application (2020-2025)
Table 31. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Drug Delivery Nanoparticles Formulation Revenue Market Share by Application (2026-2031)
Table 33. North America Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Country (2026-2031) & (US$ Million)
Table 48. CD Bioarticles Company Details
Table 49. CD Bioarticles Business Overview
Table 50. CD Bioarticles Drug Delivery Nanoparticles Formulation Product
Table 51. CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 52. CD Bioarticles Recent Development
Table 53. Evonik Health Care Company Details
Table 54. Evonik Health Care Business Overview
Table 55. Evonik Health Care Drug Delivery Nanoparticles Formulation Product
Table 56. Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 57. Evonik Health Care Recent Development
Table 58. Sanner Company Details
Table 59. Sanner Business Overview
Table 60. Sanner Drug Delivery Nanoparticles Formulation Product
Table 61. Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 62. Sanner Recent Development
Table 63. Lubrizol Life Science Health (LLS Health) Company Details
Table 64. Lubrizol Life Science Health (LLS Health) Business Overview
Table 65. Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Product
Table 66. Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 67. Lubrizol Life Science Health (LLS Health) Recent Development
Table 68. Kindeva Drug Delivery Company Details
Table 69. Kindeva Drug Delivery Business Overview
Table 70. Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Product
Table 71. Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 72. Kindeva Drug Delivery Recent Development
Table 73. Beijing TheraXyte Biotechnology Company Details
Table 74. Beijing TheraXyte Biotechnology Business Overview
Table 75. Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Product
Table 76. Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 77. Beijing TheraXyte Biotechnology Recent Development
Table 78. Altasciences Company Details
Table 79. Altasciences Business Overview
Table 80. Altasciences Drug Delivery Nanoparticles Formulation Product
Table 81. Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 82. Altasciences Recent Development
Table 83. Stevanato Group Company Details
Table 84. Stevanato Group Business Overview
Table 85. Stevanato Group Drug Delivery Nanoparticles Formulation Product
Table 86. Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 87. Stevanato Group Recent Development
Table 88. RiboBio Company Details
Table 89. RiboBio Business Overview
Table 90. RiboBio Drug Delivery Nanoparticles Formulation Product
Table 91. RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 92. RiboBio Recent Development
Table 93. Lonza Company Details
Table 94. Lonza Business Overview
Table 95. Lonza Drug Delivery Nanoparticles Formulation Product
Table 96. Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 97. Lonza Recent Development
Table 98. Thermo Fisher Scientific Company Details
Table 99. Thermo Fisher Scientific Business Overview
Table 100. Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Product
Table 101. Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 102. Thermo Fisher Scientific Recent Development
Table 103. Catalent Company Details
Table 104. Catalent Business Overview
Table 105. Catalent Drug Delivery Nanoparticles Formulation Product
Table 106. Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 107. Catalent Recent Development
Table 108. Asymchem Company Details
Table 109. Asymchem Business Overview
Table 110. Asymchem Drug Delivery Nanoparticles Formulation Product
Table 111. Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 112. Asymchem Recent Development
Table 113. Samsung Biologics Company Details
Table 114. Samsung Biologics Business Overview
Table 115. Samsung Biologics Drug Delivery Nanoparticles Formulation Product
Table 116. Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2020-2025) & (US$ Million)
Table 117. Samsung Biologics Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Drug Delivery Nanoparticles Formulation Picture
Figure 2. Global Drug Delivery Nanoparticles Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Delivery Nanoparticles Formulation Market Share by Type: 2024 VS 2031
Figure 4. Oral Preparation Features
Figure 5. Injectable Preparations Features
Figure 6. Skin Preparations Features
Figure 7. Others Features
Figure 8. Global Drug Delivery Nanoparticles Formulation Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Drug Delivery Nanoparticles Formulation Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Delivery Nanoparticles Formulation Report Years Considered
Figure 14. Global Drug Delivery Nanoparticles Formulation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Drug Delivery Nanoparticles Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug Delivery Nanoparticles Formulation Market Share by Region: 2024 VS 2031
Figure 17. Global Drug Delivery Nanoparticles Formulation Market Share by Players in 2024
Figure 18. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery Nanoparticles Formulation Revenue in 2024
Figure 20. North America Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 22. United States Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 26. Germany Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Region (2020-2031)
Figure 34. China Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 42. Mexico Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Country (2020-2031)
Figure 46. Turkey Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Drug Delivery Nanoparticles Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. CD Bioarticles Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 50. Evonik Health Care Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 51. Sanner Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 52. Lubrizol Life Science Health (LLS Health) Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 53. Kindeva Drug Delivery Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 54. Beijing TheraXyte Biotechnology Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 55. Altasciences Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 56. Stevanato Group Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 57. RiboBio Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 58. Lonza Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 60. Catalent Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 61. Asymchem Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 62. Samsung Biologics Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232